Direct contact in inviting high-risk members of hereditary colon cancer families to genetic counselling and DNA testing

Journal of Medical Genetics

Volumn 44, Issue 11, 2007, Pages 732-738

  Aktan Collan, Kartja ^a   Haukkala, A ^a   Pylvanainen K ^e   Jarvinen H J ^d   Aaltonen, L A ^a   Peltomaki P ^a   Rantanen, E ^b   Kaariainen H ^b,c   Mecklin, J P ^e  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^e JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; DNA DETERMINATION; FAMILIAL CANCER; FAMILY STUDY; FEMALE; GENE MUTATION; GENETIC COUNSELING; GENETIC PREDISPOSITION; GENETIC RISK; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT INFORMATION; PATIENT SATISFACTION; PREDICTION; PRIORITY JOURNAL; RELATIVE; SOCIAL PSYCHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ATTITUDE; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; COMMUNICATION; CORRESPONDENCE AS TOPIC; DNA MUTATIONAL ANALYSIS; DUTY TO WARN; FAMILY RELATIONS; FEMALE; FINLAND; GENETIC COUNSELING; HUMANS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PERSUASIVE COMMUNICATION; PROFESSIONAL-PATIENT RELATIONS; PSYCHOLOGY; RISK; TELEPHONE;

EID: 36349002802     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.2007.051581     Document Type: Article

References (32)

1. Claes E, Evers-Kiebooms G, Boogaerts A, Decruyenaere M, Denayer L, Legius E. Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients. Am J Med Genet 2003;116A:11-19.
2. Hallowell N, Ardern-Jones A, Eeles R, Foster C, Lucassen A, Moynihan C, Watson M. Communication about genetic testing in families of male BRCA1/2 carriers and non-carriers: Patterns, priorities and problems. Clin Genet 2005;67:492-502.
3. Hughes C, Lerman C, Schwartz M, Peshkin B, Wenzel L, Narod S, Corio C, Tercyak KP, Hanna D, Isaacs C, Main D. All in the family: evaluation of the process and content of sisters' communication about BRCA1 and BRCA2 genetic test results. Am J Med Genet 2002;107:143-50.
4. Kenen R, Arden-Jones A, Eeles R. We are talking, but are they listening? Communication patterns in families with a history of breast/ovarian cancer (HBOC). Psychooncology 2004;13:335-45.
5. Mesters I, Ausems M, Eichhorn S, Vasen H. Informing one's family about genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): A retrospective exploratory study. Fam Cancer 2005;4:163-7.
6. Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med 2003;348:919-32.
7. Vasen HF, Wijnen JT, Menko FH, Kleibeuker JH, Taal BG, Griffjoen G, Nagengast FM, Meijers-Hejboer EH, Bertario L, Varesco L, Bisgaard ML, Mohr J, Fodde R, Khan PM. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 1996;110:1020-7.
8. Aarnio M, Sankila R, Pukkala E, Salovaara R, Aaltonen LA, de le Chapelle A, Peltomäki P, Mecklin JP, Järvinen HJ. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 1999;81:214-18.
9. Järvinen HJ, Aarnio M, Mustonen H, Aktan-Collan K, Aaltonen LA, Peltomäki P, de la Chapelle A, Mecklin JP. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 2000;118:829-34.
10. de Jong AE, Hendriks YMC, Kleibeuker JH, de Boer SY, Cats A, Griffioen G, Nagengast FM, Nelis FG, Rookus MA, Vasen HFA. Decrease in mortality in Lynch syndrome families because of surveillance. Gastroenterology 2006;130:665-71.
11. ASHG statement: Professional disclosure of familial genetic information. The American Society of Human Genetics Social Issues Subcommittee on Familial Disclosure. Am J Hum Genet 1998;62:474- 83.
12. ASCO Working Group on Genetic Testing for Cancer Susceptibility. American society of clinical oncology policy statement update. Genetic testing for cancer susceptibility. J Clin Oncol 2003;21:2397-06.
13. Falk MJ, Dugan RB, O'Riordan MA, Matthews AL, Robin NH. Medical geneticists' duty to warn at-risk relatives for genetic disease. Am J Med Genet 2003;120A:374-80.
14. Offit K, Groeger E, Turner SJD, Wadsworth EA, Weiser MAJD. The "duty to warn" a patient's family members about hereditary disease risks. JAMA 2004;292:1469-73.
15. de Wert G. Cascade screening: Whose information is it anyway? Eur J Hum Genet 2005;13:397-8.
16. Newson AJ, Humphries SE. Cascade testing in familial hypercholesterolaemia: how should family members be contacted? Eur J Hum Genet 2005;13:401-8.
17. Godard B, Hurlimann T, Letendre M, Egalite N, Inherit BRCAs. Guidelines for disclosing genetic information to family members: From development to use. Fam Cancer 2006;5:103-16.
18. Svendsen MN, Koch L. Genetics and prevention: a policy in the making. New Genet Soc 2006;25:51-68.
19. Tupasela A. When legal worlds collide: From research to treatment in hereditary cancer prevention. Eur J Cancer Care 2006;15:257-66.
20. Aktan-Collan K, Mecklin JP, Jarvinen H, Nyström-Lahti M, Peltomäki P, Söderling I, Uutela A, de la Chapelle A, Kääriäinen H. Predictive genetic testing for hereditary non-polyposis colorectal cancer: Uptake and long-term satisfaction. Int J Cancer 2000;89:44-50.
21. Aktan-Collan K, Haukkala A, Mecklin JP, Uutela A, Kaariainen H. Psychological consequences of predictive genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): A prospective follow-up study. Int J Cancer 2001;93:608-11.
22. Aktan-Collan K, Haukkala A, Mecklin JP, Uutela A, Kaariainen H. Comprehension of cancer risk one and 12 months after predictive genetic testing for hereditary non-polyposis colorectal cancer. J Med Genet 2001;38:787-92.
23. Meiser B, Collins V, Warren R, Gaff C, St John DJ, Young MA, Harrop K, Brown J, Halliday J. Psychological impact of genetic testing for hereditary non-polyposis colorectal cancer. Clin Genet 2004;66:502-11.
24. Claes E, Denayer L, Evers-Kiebooms G, Boogaerts A, Philippe K, Tejpar S, Devriendt K, Legius E. Predictive testing for hereditary nonpolyposis colorectal cancer: Subjective perception regarding colorectal and endometrial cancer, distress, and health-related behavior at one year post-test. Genet Test 2005;9:54-65.
25. Gritz ER, Peterson SK, Vernon SW, Marani SK, Baile WF, Watts BG, Amos IC, Frazier ML, Lynch PM. Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer. J Clin Oncol 2005;23:1902-10.
26. Rantanen E, Hietala M, Kääriäinen H. Summary of the guidelines for genetic counselling, 2006. http://en.eurogentest.org/files/ public/unit3/summaryofguidelinesMay06.pdf.
27. Pylvänäinen K, Kairaluoma M, Mecklin JP. Compliance and satisfaction with long-term surveillance in Finnish HNPCC families. Fam Cancer 2006;5:175-8.
28. Spielberger CD, Gorsuch RL, Lushene R. State-Trait Anxiety Inventory manual. Palo Alto, CA: Consulting Psychologist Press, 1970.
29. Suthers GK, Armstrong J, McCormack J, Trott D. Letting the family know: balancing ethics and effectiveness when notifying relatives about genetic testing for a familial disorder. J Med Genet 2006;43:665-70.
30. Ponz de Leon M, Benatti P, Di Gregorio C, Pedroni M, Losi L, Genuardi M, Viel A, Fornasarig M, Lucci-Cordisco E, Anti M, Ponti G, Borghi F, Lamberti I, Roncucci L. Genetic testing among high-risk individuals in families with hereditary nonpolyposis colorectal cancer. Br J Cancer 2004;90:882-7.
31. Church J, Kay S, Senae J. The benefits of genetic counselling in families likely to have HNPCC and why families do not get it. Dis Colon Rect, 2005;616.(Abstract)..
32. Douglas JA, Gruber SB, Meister KA, Bonner J, Watson P, Krush AJ, Lynch HT. History and molecular genetics of Lynch syndrome in family G: A century later. JAMA 2005;294:2195-202.